BridgeMD
New treatment option for Recurrent Nasopharyngeal Carcinoma
Official title Proton Therapy for Recurrent Nasopharyngeal Carcinoma
ClinicalTrials.gov ID: NCT07412314
What this study is testing
- What it's testing
- The above studies show that most of the supportive evidence for the reduction of toxicity and improvement of efficacy of proton therapy for recurrent Nasopharyngeal carcinoma(NPC) comes from various observational and retrospective studies, lacking high-level evidence-based medical evidence. The conduct of this study will explore the safety and efficacy of intensity-modulated proton radiotherapy for recurrent NPC and provide more high-quality evidence-based medical evidence for proton therapy of recurrent cancer.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Non-metastatic squamous cell carcinoma of the nasopharynx with biopsy confirmation, at stage ≥ T2b and/or with positive lymph nodes, (2) Pathological...
- PS score (according to Eastern Cooperative Oncology Group (ECOG) standard) 0-1. Age ≥ 18 years.
- Expected survival period ≥ 6 months
- Before treatment, evaluate the tumor range and size of the patient.
- Nutritional and general physical condition must be able to tolerate the recommended radiotherapy and chemotherapy.
You likely can't join if
- Evidence of distant metastasis in stage IVc
- Patients with isolated recurrence of cervical lymph nodes;
- Patients have participated in other treatment trials for tumors
- Having suffered from other malignant tumors within 5 years (excluding melanoma skin cancer) or tumors originating from the head and neck region...
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
- Guanzhou, Guangzhou, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China; Guanzhou, Guangzhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.